Boston Common Asset Management’s Hologic HOLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-272,320
Closed -$16.8M 306
2025
Q1
$16.8M Buy
272,320
+44,756
+20% +$2.97M 0.51% 73
2024
Q4
$16.4M Sell
227,564
-79,101
-26% -$6.18M 0.48% 80
2024
Q3
$25M Buy
306,665
+831
+0.3% +$66.5K 0.65% 45
2024
Q2
$22.7M Sell
305,834
-31,035
-9% -$2.33M 0.58% 59
2024
Q1
$26.3M Sell
336,869
-43,875
-12% -$3.26M 0.63% 50
2023
Q4
$27.2M Sell
380,744
-15,665
-4% -$1.09M 0.62% 55
2023
Q3
$27.5M Buy
396,409
+59,020
+17% +$4.46M 0.66% 53
2023
Q2
$27.3M Buy
337,389
+124,182
+58% +$10.1M 0.58% 65
2023
Q1
$17.2M Sell
213,207
-3,210
-1% -$258K 0.36% 109
2022
Q4
$16.2M Buy
216,417
+13,047
+6% +$929K 0.77% 53
2022
Q3
$13.1M Buy
203,370
+99,090
+95% +$6.86M 0.69% 57
2022
Q2
$7.23M Buy
+104,280
New +$7.74M 0.36% 86

Other funds holding HOLX

Boston Common Asset Management's HOLX Position: Q2 2025 in Review

Boston Common Asset Management sold out of Hologic (HOLX) in Q2 2025, closing a stake of 272,320 shares — an estimated $16.8M sold.

Boston Common Asset Management first reported a position in HOLX in Q2 2022 and held it in 12 quarters. The position peaked at $27.5M in Q3 2023. 692 funds tracked by Wall St. Rank hold HOLX as of Q2 2025.

  • Boston Common Asset Management reported no remaining Hologic position as of Q2 2025 after selling out during the quarter.
  • Boston Common Asset Management sold 272,320 Hologic shares in Q2 2025, an estimated $16.8M.
  • Boston Common Asset Management first reported a position in Hologic in Q2 2022 and held it in 12 quarters.
  • Boston Common Asset Management's Hologic position peaked at $27.5M in Q3 2023.
  • 692 funds tracked by Wall St. Rank held Hologic as of Q2 2025.

Based on Boston Common Asset Management's 13F filing for Q2 2025, filed 22 Jul 2025.